The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1451
September 15, 2014
View Complete Issue         Table of Contents 2019 
Efinaconazole Topical Solution (Jublia) for Onychomycosis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Efinaconazole Topical Solution (Jublia) for Onychomycosis
September 15, 2014 (Issue: 1451)
The FDA has approved efinaconazole 10% solution (Jublia – Valeant) for topical treatment of toenail onychomycosis due to Trichophyton rubrum and/or Trichophyton mentagrophytes. It is the first topical triazole antifungal drug to be approved for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Efinaconazole Topical Solution (Jublia) for Onychomycosis
Article code: 1451c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.